HARTFORD, CT — State regulators in Connecticut have moved to expand the pool of patients eligible to receive cannabis therapy.
Earlier this month, members of the state’s Board of Physicians voted to allow doctors to recommend medical cannabis to patients diagnosed with Tourette syndrome, MALS syndrome (medial arcuate ligament syndrome), vulvodynia (burning irritation), interstitial cystitis, and neuropathic pain (that is unresponsive to conventional treatments).
Board members postponed making a decision regarding whether to include those patients with more generalized chronic pain.
Over 33,000 patients are registered with the state to access medical cannabis.
